woman-smartphone-girl-technology

Smartphone app for treating depression launches in UK

Ella Day | June 17, 2025 | News story | Clinical & Scientific, Freelancers NHS trusts, Psychiatry, Rejoyn, digital therapeutics, major depressive disorder, mental health 

Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The smartphone app is designed to be used alongside existing treatments and is currently being deployed within select NHS Trusts, with broader uptake anticipated over the coming year.

Rejoyn delivers a six-week cognitive training programme that aims to improve emotional regulation by strengthening neural connections in brain regions affected by depression. This approach differs from other digital therapies that typically focus on cognitive behavioural therapy.

The treatment is supported by results from the MIRAI clinical study, which evaluated the app’s effectiveness in patients with MDD who were already receiving antidepressant medication. Compared with a sham control, those using Rejoyn experienced greater reductions in depression severity, as measured by the Montgomery-Åsberg Depression Rating Scale. Improvements were also seen on the Patient Health Questionnaire and Clinical Global Impression – Severity scale. Continued symptom improvement was observed up to week ten, suggesting a durable treatment effect.

Advertisement

Approximately one in six UK adults will experience moderate-to-severe depressive symptoms in their lifetime, with prevalence rising in recent years. Despite available treatments, nearly half of patients do not respond adequately to current therapies.

“Rejoyn is a prime example of how new technologies can complement existing approaches to care,” said Ryan Gynne, managing director at Otsuka UK.

The UK launch is Rejoyn’s first in Europe and forms part of Otsuka and Click’s global expansion strategy for digital therapeutics.

Ella Day
17/6/25

The Pharmafile Brief

This article featured in: July 2025 – The Pharmafile Brief

Related Content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

The Gateway to Local Adoption Series

Latest content